# reload+after+2024-01-23 12:44:47.398852
address1§One Patriots Park
city§Bedford
state§MA
zip§01730
country§United States
phone§781 301 7277
website§https://www.homologymedicines.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. The company's various set of AAVHSCs allows company to precisely target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, blood-brain-barrier, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
fullTimeEmployees§92
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Paul  Alloway J.D., Ph.D.', 'age': 52, 'title': 'President & COO', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 661451, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Saswati  Chatterjee Ph.D.', 'title': 'Co-Founder & Member of Scientific Advisory Board', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Charles  Michaud Jr., CPA', 'title': 'VP of Finance, Corporate Controller & Treasurer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Theresa  McNeely', 'age': 59, 'title': 'Chief Communications Officer & Patient Advocate', 'yearBorn': 1964, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Melissa  Gelormini', 'title': 'Senior Vice President of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§6
boardRisk§7
compensationRisk§8
shareHolderRightsRisk§8
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.176
priceToSalesTrailing12Months§18.37119
currency§USD
dateShortInterest§1702598400
forwardEps§-0.69
pegRatio§0.03
exchange§NMS
quoteType§EQUITY
shortName§Homology Medicines, Inc.
longName§Homology Medicines, Inc.
firstTradeDateEpochUtc§1522243800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§f4ef6c71-c33b-30e3-8521-80d7aed6ba1c
gmtOffSetMilliseconds§-18000000
targetHighPrice§1.5
targetLowPrice§1.5
targetMeanPrice§1.5
targetMedianPrice§1.5
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§4.084
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
